Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab (Q80704669)
Jump to navigation
Jump to search
scientific article published on 01 August 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab |
scientific article published on 01 August 2007 |
Statements
Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab (English)
Shirin Khambata-Ford
Christopher R Garrett
Neal J Meropol
Mark Basik
Christopher T Harbison
Shujian Wu
Tai W Wong
Xin Huang
Chris H Takimoto
Andrew K Godwin
Benjamin R Tan
Smitha S Krishnamurthi
Howard A Burris
Elizabeth A Poplin
Jose Baselga
Edwin A Clark